Relapsed or Refractory Lymphoma Trial in Russia
Global Clinical Trials is initiating a Phase I clinical study in Relapsed or Refractory Lymphoma for a US biotechnology company, OncoTartis, Inc.
GCT will be responsible for the local study management throughout all stages of the trial, including start-up activities, regulatory submission to Ministry of Health and Local Ethics Committees, project and site management, clinical monitoring, and the full cycle of the complex study logistics.
November 12, 2020
Endometriosis safety follow-up study in Ukraine
Global Clinical Trials launches new gynecology study in Ukraine. The project is sponsored by young EU biopharma company focused on research in women’s health.
It is a multicenter, open-label, single-arm Phase III study in 160 patients suffering from endometriosis. The study will be conducted at up to 13 sites in Ukraine.
November 12, 2020
GCT enhances European presence through a strategic acquisition in Baltic States
Global Clinical Trials announces the acquisition of a long-time collaborator Larrey Ltd. GCT will now offer in-house regulatory affairs, clinical monitoring, site and project management, IMP and clinical trial materials logistics and other support in Estonia, Latvia, and Lithuania.
November 11, 2020
GCT announces expansion to the country of Georgia
Yesterday Global Clinical Trials, LLC announced the launch of full-service clinical operations in Georgia by opening a new office in Tbilisi. Having successfully conducted clinical trials there, we are now pleased to announce this new corporate milestone.
November 2, 2020
First Patient In Acute Infection Clinical Trial In Russia
Despite the COVID-19 challenging the routine of clinical trials worldwide, Global Clinical Trials has successfully randomized the first patient into a clinical trial evaluating the efficacy of IP in the sore throat pain relief.
This is a phase IV, multicenter, randomized, non-inferiority trial aiming to enroll over 300 patients globally. The first patient was enrolled only 4 days after the site activation.
October 8, 2020
Database Locked for the Rare Disease Pediatric Study
GCT team is proud for taking part in achievement of the major milestone for the Phase III clinical trial.
The study is being successfully conducted, amidst the present difficult global environment, in pediatric patients suffering from a rare neurological disease. In January 2020, GCT has successfully completed the enrollment of patients in Russia. We have now reached the next milestone – the Database Lock.
September 7, 2020
Multiple Sclerosis Observational Study in Georgia
Global Clinical Trials is managing its first local project in Georgia. It is a recently awarded observational Phase IV clinical trial in Multiple Sclerosis.
GCT team is performing local management of the multinational study sponsored by an international Big Pharma. It includes trainings, regulatory documentation handling, adjustment and submission of amendments, site monitoring and close-out, and the eTMF maintenance.
September 1, 2020
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.
